Hanmi Pharm Ltd. (128940)
128940 · Health Care · 
Korea
Hanmi Pharm Ltd. (128940) is a company in the Health Care sector, based in Korea. The stock is held in 1 ETF we track – with its largest weight of 0.02 % in IS3N (msci-em-imi). Anyone holding one of these ETFs also owns a small indirect stake in Hanmi Pharm.
How many funds hold this stock?
Low ETF coverage: 1 of the 95 ETFs we cover holds Hanmi Pharm, spread across one index. That places it among the least widely held names in index funds — of the 4,334 stocks we cover, none sits in fewer ETFs.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is Hanmi Pharm in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IS3N | msci-em-imi | 0.02 % | €0.20 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Hanmi Pharm as of the fund's latest holdings list.
Weight in IS3N since 2019
In IS3N, a fund tracking the MSCI EM IMI, Hanmi Pharm had a weight of 0.02 % on Sep 30, 2019 and 0.02 % on Sep 18, 2026. Its share peaked at 0.03 % on Mar 31, 2020. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.
How much Hanmi Pharm Ltd. overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Hanmi Pharm — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| Liga Chem Bio Inc. | 141080 | 1 | – |
| SK Bioscience | 302440 | 1 | – |
| Orum Therapeutic | 475830 | 1 | – |
| Shandong Weigao GP Medical Polymer | 1066 | 1 | – |
| Jinxin Fertility Group | 1951 | 1 | – |
| Ssy Group Ltd. | 2005 | 1 | – |
| Saudi Pharmaceutical Indust and Me | 2070 | 1 | – |
| Microport Neurotech Corp. | 2172 | 1 | – |
